NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Cardone Ventures Makes $89M Bid for PetMeds

Cardone Ventures, led by Grant Cardone and Brandon Dawson, submits $4.25/share cash offer to acquire PetMed Express, valuing the pet pharmacy at $89 million.

Cardone Ventures Makes $89M Bid for PetMeds
Photo by Krista Mangulsone on Unsplash
Already have an account? Sign in.
12/16/2025 · 12:57 PM
PETS
/ Don’t stop at just one post.

Related↓

PetMed Shares Surge on $4 Buyout Proposal from SilverCape Investments
12/11/2025 · 11:52 AM

PetMed Shares Surge on $4 Buyout Proposal from SilverCape Investments

PetMed stock jumps after revealing a $4-per-share take-private proposal from SilverCape Investments. The board is reviewing the unsolicited offer amid years of declining performance.

/ Subscriber only
/ Read more

Feed↓

D-Wave’s Q1 Sales Disappoint, but Backlog Shows 2026 Could Be Huge
05/12/2026 · 8:59 AM

D-Wave’s Q1 Sales Disappoint, but Backlog Shows 2026 Could Be Huge

D-Wave revenue missed but loss smaller; bookings surged to $33.4M from big deals.

/ Subscriber only
MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
05/12/2026 · 8:31 AM

MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics sells manufacturing site to Bora for $122.5M, keeps access, gains cash, and focuses on cancer drug development.

/ Subscriber only
Rigel Pharmaceuticals Lands Exclusive Global Deal for Breakthrough Breast Cancer Drug Veppanu
05/12/2026 · 8:05 AM

Rigel Pharmaceuticals Lands Exclusive Global Deal for Breakthrough Breast Cancer Drug Veppanu

Arvinas & Pfizer partner with Rigel to launch Veppanu, a new oral breast cancer drug showing strong results and better survival.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe